Resverlogix Corp. (RVXCF)

Currency in USD
0.1142
-0.0478(-29.51%)
Closed·
RVXCF Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
Fair Value
Day's Range
0.11100.1595
52 wk Range
0.02300.2102
Key Statistics
Prev. Close
0.162
Open
0.1595
Day's Range
0.111-0.1595
52 wk Range
0.023-0.2102
Volume
157.98K
Average Volume (3m)
30.96K
1-Year Change
228.16%
Book Value / Share
-0.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RVXCF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Resverlogix Corp. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Resverlogix Corp. Company Profile

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company’s lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Compare RVXCF to Peers and Sector

Metrics to compare
RVXCF
Peers
Sector
Relationship
P/E Ratio
−3.1x−2.9x−0.5x
PEG Ratio
0.08−0.040.00
Price/Book
−0.5x−0.6x2.6x
Price / LTM Sales
-6.5x3.2x
Upside (Analyst Target)
-275.0%40.5%
Fair Value Upside
Unlock4.4%4.4%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RVXCF Income Statement

FAQ

What Stock Exchange Does Resverlogix Corp. Trade On?

Resverlogix Corp. is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Resverlogix Corp.?

The stock symbol for Resverlogix Corp. is "RVXCF."

What Is the Resverlogix Corp. Market Cap?

As of today, Resverlogix Corp. market cap is 32.35M.

What Is Resverlogix Corp.'s Earnings Per Share (TTM)?

The Resverlogix Corp. EPS (TTM) is -0.05.

From a Technical Analysis Perspective, Is RVXCF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Resverlogix Corp. Stock Split?

Resverlogix Corp. has split 0 times.

How Many Employees Does Resverlogix Corp. Have?

Resverlogix Corp. has 19 employees.

What is the current trading status of Resverlogix Corp. (RVXCF)?

As of 25 Jul 2025, Resverlogix Corp. (RVXCF) is trading at a price of 0.11, with a previous close of 0.16. The stock has fluctuated within a day range of 0.11 to 0.16, while its 52-week range spans from 0.02 to 0.21.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.